LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
Subscribe To Our Newsletter & Stay Updated
